[CITATION][C] SCD1 confers temozolomide resistance to human glioma cells via the Akt/GSK3beta/beta-catenin signaling axis. Front Pharmacol 8: 960

S Dai, Y Yan, Z Xu, S Zeng, L Qian, L Huo, X Li, L Sun… - 2017